메뉴 건너뛰기
British Journal of Cancer
Volumn 82, Issue 10, 2000, Pages 1625-1626
Can biological markers improve the management of breast cancer patients?
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROTEIN P53;
EID: 0034057311     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (3)
References (9)
  • 1
    • 0032190388 scopus 로고    scopus 로고
    • Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: The need for quality assurance
    • Barnes DM, Millis RR, Beex LVAM, Thorpe SM and Leake RE (1998) Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. Eur J Cancer 34: 1677-1682
    • (1998) Eur J Cancer , vol.34 , pp. 1677-1682
    • Barnes, D.M.1    Millis, R.R.2    Lvam, B.3    Thorpe, S.M.4    Leake, R.E.5
  • 2
    • 0032537396 scopus 로고    scopus 로고
    • Tamoxifen for early breast cancer: An overview of the randomised trials
    • Early Breast Cancer Trialists Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351: 1451-1467
    • (1998) Lancet , vol.351 , pp. 1451-1467
  • 3
    • 0030952419 scopus 로고    scopus 로고
    • Oestrogen receptors and breast cancer
    • Elledge ME and Osborne CK (1997) Oestrogen receptors and breast cancer. Br Med J 314: 1843-1844
    • (1997) Br Med J , vol.314 , pp. 1843-1844
    • Elledge, M.E.1    Osborne, C.K.2
  • 4
    • 10244261646 scopus 로고    scopus 로고
    • Tumour marker utility grading system: A framework to evaluate clinical utility of tumour markers
    • Hayes DF, Bast RC, Desch CF et al (1996) Tumour marker utility grading system: a framework to evaluate clinical utility of tumour markers. J Natl Cancer Inst 88: 1456-1466
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1456-1466
    • Hayes, D.F.1    Bast, R.C.2    Desch, C.F.3
  • 5
    • 0030807491 scopus 로고    scopus 로고
    • Prediction of hormone sensitivity - The receptor years and onwards
    • Leake RE (1997) Prediction of hormone sensitivity - the receptor years and onwards. Endocrine-related Cancer 4: 289-296
    • (1997) Endocrine-related Cancer , vol.4 , pp. 289-296
    • Leake, R.E.1
  • 6
    • 0001925258 scopus 로고    scopus 로고
    • Oestrogen receptor status in management of breast cancer in UK
    • Mander BJ, Heal K, Purushotham AD and Wishart GC (1998) Oestrogen receptor status in management of breast cancer in UK. Lancet 352: 36-37
    • (1998) Lancet , vol.352 , pp. 36-37
    • Mander, B.J.1    Heal, K.2    Purushotham, A.D.3    Wishart, G.C.4
  • 7
    • 0028940563 scopus 로고
    • Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories
    • Romain S, Laine Bidron C, Martin PM and Magdelenat H (1995) Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. Eur J Cancer 31A: 411-417
    • (1995) Eur J Cancer , vol.31 A , pp. 411-417
    • Romain, S.1    Laine Bidron, C.2    Martin, P.M.3    Magdelenat, H.4
  • 8
    • 0030857717 scopus 로고    scopus 로고
    • Clinical impact of the plasminogen activator system in tumour invasion and metastasis: Prognostic relevance and target for therapy
    • Schmitt M, Harbeck N, Thomssen C et al (1997) Clinical impact of the plasminogen activator system in tumour invasion and metastasis: prognostic relevance and target for therapy. Thrombos Haemostas 78: 285-296
    • (1997) Thrombos Haemostas , vol.78 , pp. 285-296
    • Schmitt, M.1    Harbeck, N.2    Thomssen, C.3
  • 9
    • 0029591205 scopus 로고
    • c-erbB 2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer
    • Stal O, Sullivan S, Wingren S et al (1995) c-erbB 2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer. Eur J Cancer 31A: 2185-2190
    • (1995) Eur J Cancer , vol.31 A , pp. 2185-2190
    • Stal, O.1    Sullivan, S.2    Wingren, S.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.